Author: Sgrulletti, Mayla; Ottaviano, Giorgio; Sangerardi, Maria; Chini, Loredana; Dellepiane, Rosa Maria; Martire, Baldassarre; Montin, Davide; Rizzo, Caterina; Moschese, Viviana
Title: One step closer to influenza vaccine inclusiveness Cord-id: 5z7krihw Document date: 2020_11_24
ID: 5z7krihw
Snippet: Flu virus infection is a common cause of acute respiratory illness, with the major incidence in pediatric age, high morbidity, and mortality. The flu vaccine is recommended for all people aged ≥6 months, unless specific contraindications are present. Younger and older age, pregnancy, chronic diseases like asthma, and immunodeficiency are risk factors for severe complications following flu infection. Thus, these categories represent the target for flu vaccine strategies in most countries. Inact
Document: Flu virus infection is a common cause of acute respiratory illness, with the major incidence in pediatric age, high morbidity, and mortality. The flu vaccine is recommended for all people aged ≥6 months, unless specific contraindications are present. Younger and older age, pregnancy, chronic diseases like asthma, and immunodeficiency are risk factors for severe complications following flu infection. Thus, these categories represent the target for flu vaccine strategies in most countries. Inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV) or liveâ€attenuated influenza virus (LAIV) are currently available, with specific precautions and contraindications. We aim to resume the current indications for vaccines in the vulnerable populations to support flu vaccination inclusiveness, in anticipation of a “universal vaccine†strategy.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date